REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Captor Therapeutics S.A. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Captor Therapeutics S.A. Profile Updated: November 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Captor Therapeutics is a Swiss-Polish biopharmaceutical company focused on the development of protein degradation drugs for cancer and autoimmune diseases. The breakthrough Targeted Protein Degradation (TPD) technology allows degradation of virtually any intracellular protein including the so-called "undruggable proteome". While the main business entity Captor GmbH operates on Basel, the company's state-of-the-art laboratories are located in Wroclaw, Poland.

Headquarters
ul. Dunska 11
Wroclaw; Dolnoslaskie; Postal Code: 54-427

Contact Details: Purchase the Captor Therapeutics S.A. report to view the information.

Website: http://www.captortherapeutics.com

Basic Information
Total Employees:
Purchase the Captor Therapeutics S.A. report to view the information.
Outstanding Shares:
Purchase the Captor Therapeutics S.A. report to view the information.
Registered Capital:
Purchase the Captor Therapeutics S.A. report to view the information.
Financial Auditors:
Purchase the Captor Therapeutics S.A. report to view the information.
Incorporation Date:
November 07, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Purchase this report to view the information.
Supervisory Board Member
Ownership Details
Purchase this report to view the information.
19.95%
Purchase this report to view the information.
12.79%
Purchase this report to view the information.
7.37%
Purchase this report to view the information.
7.31%
Purchase this report to view the information.
6.5%
Company Performance
Financial values in the chart are available after Captor Therapeutics S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
91.65%▲
Total operating revenue
-15.08%▼
Operating profit (EBIT)
50.88%▲
EBITDA
54.07%▲
Net Profit (Loss) for the Period
49.79%▲
Total assets
-33.58%▼
Total equity
-40.61%▼
Operating Profit Margin (ROS)
680.4%▲
Net Profit Margin
649.33%▲
Return on Equity (ROE)
13.2%▲
Debt to Equity Ratio
7.97%▲
Quick Ratio
-0.67%▼
Cash Ratio
-0.49%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo